Matching-Adjusted Indirect Comparisons of Lorlatinib Versus Chemotherapy for Patients With Second-Line or Later Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer
- Resource Type
- Article
- Source
- In
Value in Health January 2023 26(1):64-70 - Subject
- Language
- ISSN
- 1098-3015